(VIANEWS) - Eldorado Gold Corporation Ordinary Shares (EGO), Navios Maritime Partners LP (NMM), Paysign (PAYS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Eldorado Gold Corporation Ordinary Shares (EGO)
23.1% sales growth and 4.99% return on equity
Eldorado Gold Corporation and its subsidiaries engage in the exploration, discovery, acquisition, financing, development, production, sale, and reclamation of mineral products, primarily in Turkey, Canada, Greece, Brazil, and Romania. The company primarily produces gold, as well as silver, lead, zinc, and iron ore. It operates five mines: Kisladag and Efemcukuru located in western Turkey, Lamaque in Canada, and Olympias and Stratoni located in northern Greece. The company was formerly known as Eldorado Corporation Ltd. and changed its name to Eldorado Gold Corporation in April 1996. Eldorado Gold Corporation was founded in 1992 and is headquartered in Vancouver, Canada.
Earnings Per Share
As for profitability, Eldorado Gold Corporation Ordinary Shares has a trailing twelve months EPS of $0.88.
PE Ratio
Eldorado Gold Corporation Ordinary Shares has a trailing twelve months price to earnings ratio of 20.01. Meaning, the purchaser of the share is investing $20.01 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.99%.Sales Growth
Eldorado Gold Corporation Ordinary Shares's sales growth is 46.5% for the current quarter and 23.1% for the next.
Moving Average
Eldorado Gold Corporation Ordinary Shares's worth is higher than its 50-day moving average of $16.64 and way above its 200-day moving average of $14.32.Revenue Growth
Year-on-year quarterly revenue growth grew by 29.8%, now sitting on 1.11B for the twelve trailing months.
2. Navios Maritime Partners LP (NMM)
22.5% sales growth and 14.47% return on equity
Navios Maritime Partners L.P. owns and operates dry cargo vessels in Asia, Europe, North America, and Australia. The company offers seaborne transportation services for a range of liquid and dry cargo commodities, including crude oil, refined petroleum, chemicals, iron ore, coal, grain, fertilizer, and containers, as well as charters its vessels under short, medium, and longer-term charters. Olympos Maritime Ltd. serves as the general partner of Navios Maritime Partners L.P. The company was founded in 2007 and is based in Monaco.
Earnings Per Share
As for profitability, Navios Maritime Partners LP has a trailing twelve months EPS of $12.89.
PE Ratio
Navios Maritime Partners LP has a trailing twelve months price to earnings ratio of 4.35. Meaning, the purchaser of the share is investing $4.35 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.47%.Revenue Growth
Year-on-year quarterly revenue growth declined by 1.4%, now sitting on 1.31B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 9, 2024, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 0.36%.
Sales Growth
Navios Maritime Partners LP's sales growth is 13.5% for the ongoing quarter and 22.5% for the next.
Yearly Top and Bottom Value
Navios Maritime Partners LP's stock is valued at $56.12 at 01:22 EST, below its 52-week high of $56.65 and way higher than its 52-week low of $21.18.
3. Paysign (PAYS)
12.4% sales growth and 35.65% return on equity
PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. It offers various services, such as transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a card processing platform. The company also develops prepaid card programs for corporate incentive and rewards, including consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, it offers Per Diem, Corporate Expense, and Business Travel Cards that allows businesses, and non–profits and government agencies the ability to control employee spending while reducing administration costs by eliminating the need for traditional expense reports. Further, the company provides payment claims processing and other administrative services; pharmacy-based voucher and copay, and medical claims and debit-based affordability programs; PaySign Premier, a demand deposit account debit card; and payment solution for source plasma collection centers, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and Mexico. The company was formerly known as 3PEA International, Inc. and changed its name to PaySign, Inc. in April 2019. PaySign, Inc. was incorporated in 1995 and is headquartered in Henderson, Nevada.
Earnings Per Share
As for profitability, Paysign has a trailing twelve months EPS of $0.15.
PE Ratio
Paysign has a trailing twelve months price to earnings ratio of 27.8. Meaning, the purchaser of the share is investing $27.8 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.65%.Volume
Today's last reported volume for Paysign is 132702 which is 26.8% below its average volume of 181309.
Previous days news about Paysign(PAYS)
- According to Zacks on Tuesday, 24 September, "While Fidelity National currently sports a Zacks Rank #1 (Strong Buy), Paysign and Remitly Global each carries a Zacks Rank of 2."
- According to Zacks on Tuesday, 24 September, "Fidelity National sports a Zacks Rank #1 (Strong Buy) at present, while Paysign and Remitly Global carry a Zacks Rank #2 (Buy). "
- According to Zacks on Wednesday, 25 September, "While Fidelity National currently sports a Zacks Rank #1 (Strong Buy), Paysign and Remitly Global each carry a Zacks Rank # 2 (Buy)."
4. Amphastar Pharmaceuticals (AMPH)
10.5% sales growth and 25.57% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $3.15.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 15.15. Meaning, the purchaser of the share is investing $15.15 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.57%.Moving Average
Amphastar Pharmaceuticals's worth is way higher than its 50-day moving average of $43.22 and above its 200-day moving average of $46.95.Volume
Today's last reported volume for Amphastar Pharmaceuticals is 227074 which is 41.34% below its average volume of 387135.
5. Stewart Information Services Corporation (STC)
9.8% sales growth and 4.26% return on equity
Stewart Information Services Corporation, through its subsidiaries, provides title insurance and real estate transaction related services in the United States and internationally. The company involves in searching, examining, closing, and insuring the condition of the title to real property. It also offers home and personal insurance services; services for tax-deferred exchanges; and digital customer engagement platform services. It also provides appraisal management, online notarization and closing, credit and real estate information, and search and valuation services. The company serves homebuyers and sellers, residential and commercial real estate professionals, mortgage lenders and servicers, title agencies and real estate attorneys, and home builders through direct operations, network of independent agencies, and other businesses. The company was founded in 1893 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Stewart Information Services Corporation has a trailing twelve months EPS of $1.56.
PE Ratio
Stewart Information Services Corporation has a trailing twelve months price to earnings ratio of 48.72. Meaning, the purchaser of the share is investing $48.72 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.26%.Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 24.4% and 66.7%, respectively.6. Plains All American Pipeline, L.P. (PAA)
7.7% sales growth and 10% return on equity
Plains All American Pipeline, L.P., through its subsidiaries, engages in the pipeline transportation, terminalling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates in two segments, Crude Oil and Natural Gas Liquids (NGL). The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and at times on barges or railcars. This segment provides terminalling, storage, and other facilities-related services, as well as merchant activities. The Natural Gas Liquids segment provides gathering, fractionation, storage, transportation, and terminalling activities. This segment also involved in ethane, propane, normal butane, iso-butane, and natural gasoline, as well as crude oil refining processes. The company was founded in 1981 and is headquartered in Houston, Texas. Plains All American Pipeline, L.P. operates as a subsidiary of Plains GP Holdings, L.P.
Earnings Per Share
As for profitability, Plains All American Pipeline, L.P. has a trailing twelve months EPS of $1.11.
PE Ratio
Plains All American Pipeline, L.P. has a trailing twelve months price to earnings ratio of 15.95. Meaning, the purchaser of the share is investing $15.95 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10%.Sales Growth
Plains All American Pipeline, L.P.'s sales growth is 7.9% for the current quarter and 7.7% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jul 31, 2024, the estimated forward annual dividend rate is 1.27 and the estimated forward annual dividend yield is 7.17%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 49.7B for the twelve trailing months.
Volume
Today's last reported volume for Plains All American Pipeline, L.P. is 1904190 which is 12.66% below its average volume of 2180300.